317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors
oleh: Leisha Emens, Naomi Hunder, Samuel Klempner, Erika Hamilton, Muralidhar Beeram, Valerie Odegard, Sue Hamke
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.